Humoral and T-Cell Mediated Response after the Third Dose of mRNA Vaccines in Patients with Systemic Lupus Erythematosus on Belimumab

Objective: To evaluate humoral and T-cell cellular-mediated immune response after three doses of SARS-CoV-2 mRNA vaccines in patients with systemic lupus erythematosus (SLE) under Belimumab. Patients and methods: 12 patients on Belimumab and 13 age-matched healthy volunteers were recruited. Patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Quartuccio, Luca, De Marchi, Ginevra, Domenis, Rossana, Cabas, Nicola, Guella, Silvia, Paradiso, Antonella, Fabro, Cinzia, Beltrami, Antonio Paolo, De Vita, Salvatore, Curcio, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917399/
https://www.ncbi.nlm.nih.gov/pubmed/36769731
http://dx.doi.org/10.3390/jcm12031083

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917399/
https://www.ncbi.nlm.nih.gov/pubmed/36769731
http://dx.doi.org/10.3390/jcm12031083

Ejemplares similares